Perimeter Medical Imaging AI (4PC) Stock Price & Analysis
4PC Stock Chart & Stats
- Day’s Range
- EUR 0.07 - EUR 0.08
- 52-Week Range
- EUR 0.07 - EUR 0.46
- Previous Close
- EUR 0.08
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 14.14M
- Enterprise Value
- EUR 35.07M
- Total Cash (Recent Filing)
- EUR 6.43M
- Total Debt (Recent Filing)
- EUR 4.01M
- Price to Earnings (P/E)
- ―
- Beta
- -0.77
- Next Earnings
- Nov 17, 2026 (Est.)
- EPS Estimate
- -0.03
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Regulatory Approval And Commercial Deployment
FDA PMA approval removes a major regulatory barrier for the AI-enabled B-Series and supports commercial adoption. The first installed systems performing procedures provide early real-world validation, creating a foundation for broader hospital conversions and future recurring revenue.
Recurring Revenue Growth
Fully recurring quarterly revenue from consumables, leases, maintenance and warranty programs indicates that deployed systems can generate repeat economics beyond initial placements. Continued utilization growth could improve revenue visibility and strengthen the commercial model as the installed base expands.
Improving Operating Discipline
Lower operating expenses and reduced cash use show that management is actively controlling the cost base while pursuing commercialization. If maintained, this discipline can extend financial flexibility, reduce the resources required to support growth, and improve operating leverage as revenue scales.
Bears Say
Persistent Losses And Cash Burn
The company remains materially loss-making and consumes cash faster than its current revenue base can support. Even with improved year-over-year trends, the limited cash cushion and continued investment needs make the timing of commercialization critical to sustaining operations without additional funding.
Higher Financial Leverage
The move toward debt-to-equity of roughly 1.0 represents a meaningful change from the company’s previously low-leverage position. Greater indebtedness reduces financial flexibility while losses continue, potentially increasing pressure on future financing and limiting the capacity to absorb execution setbacks.
Early Commercial Scale And Adoption Delays
B-Series commercialization remains at an early stage, and hospital AI and IT review processes can lengthen sales cycles across institutions. Delayed conversions or deployments would slow installed-base growth, postpone recurring utilization revenue, and make management’s planned revenue acceleration harder to achieve.
Perimeter Medical Imaging AI News
4PC FAQ
What was Perimeter Medical Imaging AI’s price range in the past 12 months?
What is Perimeter Medical Imaging AI’s market cap?
When is Perimeter Medical Imaging AI’s upcoming earnings report date?
How were Perimeter Medical Imaging AI’s earnings last quarter?
Is Perimeter Medical Imaging AI overvalued?
Does Perimeter Medical Imaging AI pay dividends?
What is Perimeter Medical Imaging AI’s EPS estimate?
How many shares outstanding does Perimeter Medical Imaging AI have?
What happened to Perimeter Medical Imaging AI’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Perimeter Medical Imaging AI?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Perimeter Medical Imaging AI
Perimeter Medical Imaging AI, Inc. is a medical technology firm focused on developing and marketing advanced imaging solutions. These innovations empower surgeons, radiologists, and pathologists to meticulously examine microscopic tissue structures directly within a clinical setting. A cornerstone offering is their optical coherence tomography (OCT) imaging system, which delivers detailed cross-sectional views of tissues to a depth of 2 millimeters, comprising the S-series OCT, B-series OCT, and an associated imaging console. Complementing this, ImgAssist, an artificial intelligence platform, streamlines image analysis. When integrated with Perimeter's OCT technology, ImgAssist becomes a robust tool, providing physicians with real-time visualization and assessment of surgical margins. This capability significantly enhances patient surgical outcomes and diminishes the necessity for subsequent operations. The company further provides a specialized image library and disposable specimen containers, catering to hospitals and cancer treatment facilities. Established in 2013, Perimeter Medical Imaging AI, Inc. operates from its headquarters in Toronto, Canada.
- Sector
- General
- Industry
- Medical - Devices
- CEO
- Adrian Mendes
- Employees
- 36
- Website
- www.perimetermed.com
- Address
- 555 Richmond Street West, Toronto, ON, M5V 3B1, CA
Perimeter Medical Imaging AI (4PC) Earnings & Revenues
4PC Earnings Call
Earnings Call SentimentPositive
The call presented a largely positive commercial and operational inflection: meaningful sequential recurring revenue growth (+31% QoQ), significant cost reductions (OpEx down 28%), improvement in net loss (down 33%), reduced operating cash burn (down 23%), FDA PMA approval for the B-Series, two initial commercial B-Series placements now performing procedures, and a CMS filing in process. Counterbalancing this are the small absolute revenue base, ongoing losses and limited cash balance (~$6.4M), early-stage commercial scale (only two B-Series in the field), and timing uncertainty driven by evolving hospital AI/IT review processes and fluid pipeline visibility. Overall, the highlights outweigh the lowlights given the regulatory milestone, initial commercial traction and improving financial trends, but execution and cash management remain critical near-term risks.
View all DE:4PC earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 2 | 5 | 15 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 0 | 0 | 12 |
